The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles Ardena has announced the full Good Manufacturing Practice (GMP) approval of its ...

Vivolta, a specialist in medical electrospinning solutions, has entered a long-term partnership with UK-based Neurochase to manufacture electrospun micro-catheters for advanced brain therapies. This ...

First patient dosed in phase 1b trial of MB310 therapy Microbiotica, a clinical-stage biopharma company, has announced the dosing of the first patient in its Phase 1b First-in-Human trial, COMPOSER-1, ...

We live in a world that increasingly demands answers – even when the questions, let alone the responses, are not an exact science. Make no mistake, the truth is complicated. Let’s take some clear and ...

As the polls tighten and June’s general election starts to seem very close indeed, we’ve got a roundup of all the major parties’ manifestos and what they would mean for healthcare in the UK. But ...

As the NHS goes, so goes pharma – so when the government talks about ‘transforming’ the health service, the industry better listen. Our cover feature this month (p33) focuses on sustainability and ...

Pharma and the NHS. It’s the greatest and longest running soap opera, in which we are all playing varying roles. As in The Queen Vic, the Rovers Return and the Wolf Pack, there are lots of diferent ...

Do you have a new product, new business focus, or a company to showcase? Increase your exposure with a Business Insight in PharmaTimes Magazine. Our flexible package means you can submit your own copy ...

Our cover feature (p31) this month takes a renewed look at how artificial intelligence is shaping an exciting new horizon for pharma and healthcare. It is clear that pharma must closely align with the ...

The National Institute for Health and Care Excellence (NICE) has announced that people with heart failure can now stay healthier remotely through advanced remote monitoring technology designed to ...

With another year almost gone it’s time once again to look back at how the pharma and healthcare industries have fared over the last 12 months. Despite a lot of upheaval last year, it’s clear that ...